Privia Health Group Inc
PRVANASDAQStock · Data from SEC EDGAR 13F · Held by 4 of 87 tracked investors
Privia Health Group Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation8
- Growth88
- Profitability30
- Quality45
- Debt100
- Stability87
- ✓It has more cash than debt.
- ✓Revenue grew 16.1% a year over 3 years.
- ✓The analysts' average target is 44% above the price.
- !Out of 100 USD of revenue, only 1.2 USD is left as net profit.
- !The stock is expensive: you pay 104.1 USD for 1 USD of annual earnings.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveFor 1 USD of annual earnings you pay 104.1 USD. Based on next year's estimates 20.6 USD.
- P/E
- 104.1×
- P/S
- 1.2×
- EV/EBITDA
- 43.6×
Is the company growing?
GrowingRevenue over 3 years grew 16.1% a year. Last year 21.4%.
Does it make money?
WeakChart PRVA
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
4HE Henry Ellenbogen Durable Capital Partners | 2.91% |
JS Jim Simons Renaissance Technologies | 0.02% |
JG Joel Greenblatt Gotham Asset Management | 0% |
Šn Švýcarská národní banka Swiss National Bank | 0% |
Frequently asked questions
How much is Privia Health Group Inc (PRVA) stock?
Privia Health Group Inc shares trade at $21.83, -1.49% over the last trading day. The price is delayed.
What is the market cap of Privia Health Group Inc?
The market cap of Privia Health Group Inc is about $2.8B and its price-to-earnings ratio (P/E) is 104.
Which big investors hold Privia Health Group Inc?
According to the latest 13F filings, 4 of 87 tracked investors hold Privia Health Group Inc, for example Henry Ellenbogen, Jim Simons, Joel Greenblatt.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.